Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
Deloitte
Argus Health
Johnson and Johnson
Medtronic
Mallinckrodt
Cipla
Chubb
Baxter

Generated: February 19, 2018

DrugPatentWatch Database Preview

Bicalutamide - Generic Drug Details

« Back to Dashboard

What are the generic sources for bicalutamide and what is the scope of bicalutamide patent protection?

Bicalutamide
is the generic ingredient in two branded drugs marketed by Accord Hlthcare, Apotex Inc, Fresenius Kabi Oncol, Kudco Ireland, Mylan, Roxane, Sandoz, Santos Biotech, Sun Pharma Global, Synthon Pharms, Teva, Watson Labs Teva, Zydus Pharms Usa Inc, and Ani Pharms Inc, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for bicalutamide. Nineteen suppliers are listed for this compound.

US Patents and Regulatory Information for bicalutamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Santos Biotech BICALUTAMIDE bicalutamide TABLET;ORAL 091011-001 Jun 10, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharma Global BICALUTAMIDE bicalutamide TABLET;ORAL 079110-001 Jul 6, 2009 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs Teva BICALUTAMIDE bicalutamide TABLET;ORAL 078634-001 Aug 28, 2009 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Oncol BICALUTAMIDE bicalutamide TABLET;ORAL 079045-001 May 13, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Synthon Pharms BICALUTAMIDE bicalutamide TABLET;ORAL 077973-001 Jul 6, 2009 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Accord Hlthcare BICALUTAMIDE bicalutamide TABLET;ORAL 078917-001 Jul 6, 2009 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva BICALUTAMIDE bicalutamide TABLET;ORAL 076932-001 Jul 6, 2009 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ani Pharms Inc CASODEX bicalutamide TABLET;ORAL 020498-001 Oct 4, 1995 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz BICALUTAMIDE bicalutamide TABLET;ORAL 078575-001 Jul 6, 2009 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Kudco Ireland BICALUTAMIDE bicalutamide TABLET;ORAL 077995-001 Jul 6, 2009 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for bicalutamide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ani Pharms Inc CASODEX bicalutamide TABLET;ORAL 020498-001 Oct 4, 1995 ➤ Sign Up ➤ Sign Up
Ani Pharms Inc CASODEX bicalutamide TABLET;ORAL 020498-001 Oct 4, 1995 ➤ Sign Up ➤ Sign Up
Ani Pharms Inc CASODEX bicalutamide TABLET;ORAL 020498-001 Oct 4, 1995 ➤ Sign Up ➤ Sign Up
Ani Pharms Inc CASODEX bicalutamide TABLET;ORAL 020498-001 Oct 4, 1995 ➤ Sign Up ➤ Sign Up
Ani Pharms Inc CASODEX bicalutamide TABLET;ORAL 020498-001 Oct 4, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
McKesson
Dow
Cipla
Harvard Business School
Cantor Fitzgerald
Julphar
Farmers Insurance
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot